Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Adagene Inc ADR (NQ: ADAG ) 2.950 +0.240 (+8.86%) Streaming Delayed Price Updated: 3:57 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,188,677 Open 2.580 Bid (Size) 2.900 (10) Ask (Size) 3.050 (10) Prev. Close 2.710 Today's Range 2.470 - 3.200 52wk Range 1.100 - 4.380 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update July 25, 2024 From Adagene Inc. Via GlobeNewswire Adagene Announces Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at Upcoming European Society for Medical Oncology (ESMO) Congress in September July 12, 2024 From Adagene Inc. Via GlobeNewswire Performance YTD +50.51% +50.51% 1 Month +7.86% +7.86% 3 Month +14.34% +14.34% 6 Month -9.79% -9.79% 1 Year +144.85% +144.85% More News Read More 12 Health Care Stocks Moving In Friday's After-Market Session May 31, 2024 Via Benzinga Adagene to Present at Investor Conferences in June May 22, 2024 From Adagene Inc. Via GlobeNewswire How Is The Market Feeling About Adagene? January 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session April 01, 2024 Via Benzinga Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update March 29, 2024 From Adagene Inc. Via GlobeNewswire Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board March 07, 2024 From Adagene Inc. Via GlobeNewswire Adagene to Present at the Leerink Partners Global Biopharma Conference 2024 February 27, 2024 From Adagene Inc. Via GlobeNewswire Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic February 09, 2024 From Adagene Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session February 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session January 22, 2024 Via Benzinga Week in Review: Lee’s Pharma Signs $138 Million Agreement For China Rights To Heart Failure Therapy January 20, 2024 Via Talk Markets Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session January 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 18, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 17, 2024 Via Benzinga Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 17, 2024 Via Benzinga Why Is Cancer Focused Adagene Stock Plummeting Today? January 17, 2024 Via Benzinga Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket January 17, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday January 17, 2024 Via InvestorPlace Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC) January 16, 2024 From Adagene Inc. Via GlobeNewswire Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium January 04, 2024 From Adagene Inc. Via GlobeNewswire Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023 November 03, 2023 From Adagene Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.